Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation (Q81208563)

From Wikidata
Jump to navigation Jump to search
scientific article published on 01 December 2004
edit
Language Label Description Also known as
English
Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation
scientific article published on 01 December 2004

    Statements

    title
    Phase I/II randomized trial evaluating the safety and clinical effects of repifermin administered to reduce mucositis in patients undergoing autologous hematopoietic stem cell transplantation (English)
    1 reference
    stated in
    Europe PubMed Central
    PubMed ID
    15623608
    reference URL
    https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:15623608%20AND%20SRC:MED&resulttype=core&format=json
    retrieved
    6 January 2020
    author name string

    Identifiers

     
    edit
      edit
        edit
          edit
            edit
              edit
                edit
                  edit
                    edit
                      Retrieved from "https://www.wikidata.org/w/index.php?title=Q81208563&oldid=1751088854"